Indivior PLC - INDV Forward P/S Multiple

Indivior - graphic logo of issuer INDV

Indivior PLC enjoys high physician trust and adheres to environmental standards in its packaging production. This forward price-to-sales chart reflects market expectations, with the current value standing at 2.40. A stable cash flow is driven by the long-term treatment of patients with addictions, providing the company with financial stability.

INDV (indivior.com) Price-to-Projected Revenue Ratio history from 02/21/2024 to 11/13/2026

INDV (Indivior Corp): analytical breakdowns and indicator data

- current price and projected stock value:
Stock Price Indivior|INDV - Broker Consensus Forecast
- issuer market value details:
Market Capitalization Indivior Corp|INDV - Company Buyout Price
- issuer book value statistics:
Accounting Value per Share Indivior|INDV - Company Book Value|Market Capitalization to Book Value Ratio indivior.com|INDV - Company Total Asset Base
- company liabilities and liquidity data:
Debt to Equity Indivior PLC|INDV - Long-Term Liabilities to Capital|Short-Term Debt to Equity Indivior PLC|INDV - Aggregate Debt Obligations|Debt to Book Value Indivior Corp|INDV - Company Long-Term Loans and Borrowings|Company Short-Term Debt Indivior|Quick Liquidity indivior.com
- net income and valuation multiples indicators:
INDV - Company Net Income|Projected Future Earnings Indivior PLC|INDV - Price to Earnings Ratio|Forward P/E Multiple Indivior Group|INDV - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Indivior Corp|INDV - Operating profit before amortization|Net earnings per share (EPS TTM) Indivior|INDV - Earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months indivior.com|INDV - Earnings per share growth in current year|Net earnings per share growth forecast for next year Indivior PLC
- sales revenue and business income indicators:
INDV - Company Sales Volume|Projected Sales Volume Indivior|INDV - P/S Multiple|Price-to-Projected Revenue Ratio Indivior Corp
Summary company analysis:Indivior (INDV)
Original product of Indivior PLC

Indivior PLC revenues are subject to the influence of regulatory norms combating opioid addiction and patent risks. By analyzing the projected price-to-sales ratio, an investor assesses the company's market value relative to expected sales volume: an inflated multiple indicates a high premium for future growth, whereas low values confirm business stagnation or maturity.

Key competitors

Forward P/S Multiple COLL (Collegium Pharmaceutical, Inc.)|CRON: Market Cap to Projected Revenue|Tweed - Forward P/S Multiple|Market Cap to Expected Sales Ratio Canna Cabana HITI|ACB (auroramj.com) - Forward Price-to-Revenue Multiple|ACHV (achievelifesciences.com) - Price-to-Projected Revenue Ratio|SKYE (Skye Bioscience) - Forward P/S Multiple|Anebulo Pharmaceuticals Inc (ANEB) - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio InterCure Ltd. (INCR)|NTRB - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Nasus Pharma NSRX|Forward Price to Sales IGC|MIRA: Forward Price-to-Revenue Multiple|Forward Price to Sales FLGC (Flora Growth Corp)|imcannabis.com (IMCC) - Price-to-Projected Revenue Ratio|Future Price to Revenue ADIL (Adial Pharmaceuticals, Inc.)|Price-to-Projected Revenue Ratio Artelo Biosciences Inc.|Price-to-Projected Revenue Ratio ENSC|Forward P/S Multiple TTNP|Forward Price-to-Revenue Multiple Greenlane Holdings, Inc. GNLN|Forward P/S Multiple INM (InMed Pharma)|Market Cap to Expected Sales Ratio Akanda Inc (AKAN)|ENVB - Price-to-Projected Revenue Ratio|BGXX (Bright Green) - Market Cap to Projected Revenue|HPCO: Forward P/S Multiple